[1] |
陈伟, 李雪, 刘小秋, 等. 《全国结核病防治规划(2024—2030年)》解读. 中国防痨杂志, 2025, 47(2):130-136. doi:10.19982/j.issn.1000-6621.20240585.
|
[2] |
Ritchie ME, Phipson B, Wu D, et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res, 2015, 43(7):e47. doi:10.1093/nar/gkv007.
|
[3] |
李根, 陶学萍, 钟希, 等. T-SPOT.TB联合胸水CD64、S100A9、ADA检测诊断结核性胸腔积液的临床价值. 中华医院感染学杂志, 2025, 35(1):25-29. doi:10.11816/cn.ni.2025-240480.
|
[4] |
Ou Y, Li D, Long X, et al. Study on the early diagnostic value of nanopore sequencing in alveolar lavage fluid smear-negative pulmonary tuberculosis. Braz J Microbiol, 2025, 56(1):365-372. doi:10.1007/s42770-024-01575-9.
pmid: 39621292
|
[5] |
Fernández-Delgado M, Cernadas E, Barro S, et al. Do we need hundreds of classifiers to solve real world classification problems?. J Mach Learn Res, 2014, 15(1):3133-3181. doi:10.5555/2627435.2697065.
|
[6] |
中华人民共和国国家卫生和计划生育委员会. WS 288—2017肺结核诊断. 结核与肺部疾病杂志, 2024, 5(4):376-378. doi:10.19983/j.issn.2096-8493.2024022.
|
[7] |
中华医学会呼吸病学分会. 恶性胸腔积液治疗的中国专家共识(2023年版). 中华结核和呼吸杂志, 2023, 46(12):1189-1203. doi:10.3760/cma.j.cn112147-20230902-00126.
|
[8] |
中华医学会呼吸病学分会胸膜与纵隔疾病学组(筹). 胸腔积液诊断的中国专家共识. 中华结核和呼吸杂志, 2022, 45(11):1080-1096. doi:10.3760/cma.j.cn112147-20220511-00403.
|
[9] |
刘波, 齐凤娥, 张建华, 等. T细胞酶联免疫斑点试验在结核性胸膜炎鉴别诊断中的应用价值. 实用医学杂志, 2015, 31(21):3592-3594. doi:10.3969/j.issn.1006-5725.2015.21.042.
|
[10] |
郑春燕, 李海, 杨莉, 等. 酶联免疫斑点技术在快速诊断结核性胸膜炎中的应用. 广东医学, 2013, 34(16):2503-2506. doi:10.3969/j.issn.1001-9448.2013.16.028.
|
[11] |
罗红辉, 刘育良, 罗忆群. T-SPOT.TB联合胸水ADA在结核性胸膜炎中的诊断价值. 广州医药, 2021, 52(1):109-111,129. doi:10.3969/j.issn.1000-8535.2021.01.022.
|
[12] |
文玉琪, 李志惠, 任欣欣, 等. 胸腔积液结核感染T细胞斑点检测与腺苷脱氨酶对结核性胸膜炎的诊断价值. 中国医刊, 2021, 56(7):732-735. doi:10.3969/j.issn.1008-1070.2021.07.011.
|
[13] |
陈德洪. 内科胸腔镜下胸膜组织Xpert MTB/RIF对诊断结核性胸膜炎的价值. 广州:广州医科大学, 2023.
|
[14] |
吴一秀. 不同指标联合检测对结核性胸膜炎的诊断价值的分析. 湛江:广东医科大学, 2023.
|
[15] |
Feller-Kopman D, Light R. Pleural Disease. N Engl J Med, 2018, 378(8):740-751. doi:10.1056/NEJMra1403503.
|
[16] |
李芳, 张坚, 郝雪琦, 等. 胸腔积液中IL-27和IFN-γ检测对结核性胸膜炎的诊断价值. 吉林大学学报(医学版), 2019, 45(2):353-358. doi:10.13481/j.1671-587x.20190224.
|
[17] |
Kim NY, Jang B, Gu KM, et al. Differential Diagnosis of Pleural Effusion Using Machine Learning. Ann Am Thorac Soc, 2024, 21(2):211-217. doi:10.1513/AnnalsATS.202305-410OC.
|
[18] |
欧阳佩珩, 胡志德, 张蕾. 新型结核性胸腔积液诊断标志物研究进展. 中国感染与化疗杂志, 2024, 24(3):371-376. doi:10.16718/j.1009-7708.2024.03.020.
|
[19] |
Dhooria S, Singh N, Aggarwal AN, et al. A randomized trial comparing the diagnostic yield of rigid and semirigid thoracoscopy in undiagnosed pleural effusions. Respir Care, 2014, 59(5):756-764. doi:10.4187/respcare.02738.
pmid: 24106326
|
[20] |
张娟, 李海芬, 李小曼, 等. 糖尿病足溃疡复发风险预测模型的构建:基于Logistic回归和支持向量机及BP神经网络模型. 中国全科医学, 2023, 26(32):4013-4019. doi:10.12114/j.issn.1007-9572.2023.0175.
|
[21] |
Aggarwal AN, Agarwal R, Dhooria S, et al. Unstimulated Pleural Fluid Interferon Gamma for Diagnosis of Tuberculous Pleural Effusion: a Systematic Review and Meta-analysis. J Clin Microbiol, 2021, 59(5):e02112-20. doi:10.1128/jcm.02112-20.
|
[22] |
Ai L, Li J, Ye T, et al. Use of Platelet Parameters in the Differential Diagnosis of Lung Adenocarcinoma-Associated Malignant Pleural Effusion and Tuberculous Pleural Effusion. Dis Markers, 2022, 2022:5653033. doi:10.1155/2022/5653033.
|
[23] |
李锐成, 郜赵伟, 董轲, 等. 胸腔积液与血清中的癌胚抗原及其比值对结核性与肺癌性胸腔积液的诊断价值. 南方医科大学学报, 2019, 39(2):175-180. doi 10.12122/j.issn.1673-4254.2019.02.08.
|
[24] |
Neves DD, Dias RM, Cunha AJ. Predictive model for the diagnosis of tuberculous pleural effusion. Braz J Infect Dis, 2007, 11(1): 83-88. doi:10.1590/s1413-86702007000100019.
pmid: 17625733
|
[25] |
Ruan SY, Chuang YC, Wang JY, et al. Revisiting tuberculous pleurisy: pleural fluid characteristics and diagnostic yield of mycobacterial culture in an endemic area. Thorax, 2012, 67(9):822-827. doi:10.1136/thoraxjnl-2011-201363.
|
[26] |
Adam SP, Alexandropoulos S-AN, Pardalos PM, et al. No Free Lunch Theorem: A Review. Berlin: Approximation and Optimization: Algorithms, Complexity and Applications, 2019: 57-82. doi:10.1007/978-3-030-12767-15.
|
[27] |
Li F, Zhu C, Zhang Y, et al. Granzyme A as biomarker for diagnosis in tuberculous pleural effusion. JCI Insight, 2024, 9(23): e185307. doi:10.1172/jci.insight.185307.
|
[28] |
Zhou X, Chen Y, Gui W, et al. Enhanced differential evolution algorithm for feature selection in tuberculous pleural effusion clinical characteristics analysis. Artif Intell Med, 2024, 153:102886. doi:10.1016/j.artmed.2024.102886.
|